Patient Guide: A Phase 1/2 Study of Inlexisertib (DCC-3116) in Patients With RAS/MAPK Pathway Mutant Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 10 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04892017
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Small Cell Lung Cancer, Advanced Solid Tumor, Metastatic Solid Tumor
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 10 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Boston, Massachusetts
  • St Louis, Missouri
  • New Brunswick, New Jersey
  • • And 7 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily